title: Nitrate tolerance in heart failure: differential venous, pulmonary and systemic arterial effects.
abstract: The hemodynamic profile of tolerance to intravenous nitroglycerin was studied in 9 patients with New York Heart Association Class III to IV congestive heart failure. After rapid dosage build-up to the maximal tolerated dose (decrease in pulmonary wedge pressure to 10 mm Hg or systolic blood pressure to 90 mm Hg), nitroglycerin (525 +/- 548 micrograms/min) was administered at a constant continuous intravenous infusion for a total of 24 hours. The extent of nitrate tolerance at 24 hours was calculated as the percentage loss of the benefit achieved at time of peak effect of nitroglycerin. Tolerance had a different time course and magnitude in the venous, arterial and pulmonary circulations. At 24 hours, right atrial pressure and pulmonary vascular resistance returned to control values in most patients, while 40 to 50% of the effect on systemic vascular resistance, cardiac index and pulmonary wedge pressure was maintained. These findings emphasize the importance of precise definitions in studies relating to nitrate tolerance.
authors.affiliation: Department of Cardiology, Lady Davis Carmel Hospital, Haifa, Israel.
authors.forename: N
authors.initials: N
authors.lastname: Makhoul
authors.forename: N
authors.initials: N
authors.lastname: Dakak
authors.forename: M Y
authors.initials: MY
authors.lastname: Flugelman
authors.forename: A
authors.initials: A
authors.lastname: Merdler
authors.forename: A
authors.initials: A
authors.lastname: Shefer
authors.forename: A
authors.initials: A
authors.lastname: Schneeweiss
authors.forename: D A
authors.initials: DA
authors.lastname: Halon
authors.forename: B S
authors.initials: BS
authors.lastname: Lewis
mesh_terms: D000328:Adult; D000368:Aged; D004361:Drug Tolerance; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D005996:Nitroglycerin